NCT02828904View on ClinicalTrials.gov

RIVET - Retrospective Cohort Study on the Risk of Venous Thromboembolism

CompletedOBSERVATIONAL
Enrollment

124,000

Participants

Timeline

Start Date

March 10, 2022

Primary Completion Date

January 15, 2024

Study Completion Date

January 31, 2024

Conditions
Venous Thromboembolism
Trial Locations (1)

10115

Center for Epidemiology and Health Research Berlin, Berlin

All Listed Sponsors
lead

Center for Epidemiology and Health Research, Germany

OTHER

NCT02828904 - RIVET - Retrospective Cohort Study on the Risk of Venous Thromboembolism | Biotech Hunter | Biotech Hunter